US: 800.298.5699
Int'l: +1.240.747.3093
Matching geography
Reports matching your search in:
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!

Dengue Market Research Reports & Industry Analysis

Find the information you need on Dengue infectious disease, clinical trials and drug development. Our collection of market research reports provides insights into product and market trends, analysis, opportunities, projections, sales, and marketing strategies. Specifics on market share, segmentation, size, and growth in the US and global markets are also featured.
RSS Feeds

Dengue Industry Research & Market Reports

Dengue - Pipeline Review, H1 2015
1/22/2015 | published by: Global Markets Direct
... Dengue, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Dengue-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... that fall under Dengue. This report provides information on the therapeutic development based on the Dengue dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, ...  |  read more...
USD 1,250
Dengue Fever Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... of dengue fever partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors dengue fever technology. These deals tend to ...  |  read more...
USD 695
Dengue Fever Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... Dengue Fever in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and ...  |  read more...
USD 670
EpiCast Report: Dengue - Epidemiology Forecast to 2023
5/5/2014 | published by: GlobalData
... most prevalent arthropod-borne diseases affecting humans. The severity of dengue fever ranges from asymptomatic cases, to classic dengue fever, and to DHF or DSS. GlobalData epidemiologists sourced government-based publications for the forecast of reported laboratory-confirmed ...  |  read more...
USD 3,995
OpportunityAnalyzer: Dengue Vaccines - Opportunity Analysis and Forecasts to 2020
7/14/2014 | published by: GlobalData
... mosquito. Thought to be responsible for upwards of 100 million infections each year, DENV is the most prevalent arthropod-borne virus in the world. Individuals infected with DENV can present with a wide spectrum of symptoms, ...  |  read more...
USD 7,995
Update: Dengue Fever Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Dengue Fever in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
Dengue Global Clinical Trials Review, H2, 2013
9/30/2013 | published by: GlobalData
... relating to the clinical trials on Dengue. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage ...  |  read more...
USD 2,500
A Product and Pipeline Analysis of the Latin American HIV, Chagas, Dengue, and Influenza H1N1 Therapeutics Markets
10/15/2013 | published by: Frost & Sullivan
... the human immunodeficiency virus (HIV), Chagas, dengue, and influenza H1N1 therapeutics markets in Latin America. General market trends are covered, and a competitive landscape, which highlights current drugs on the market as well as drugs ...  |  read more...
USD 4,000
What's Next In Vaccines (Malaria, Diabetes, Alzheimer's, Allergies and 30 Other Targets in the 2012-2021 Vaccine Pipeline)
6/5/2012 | published by: Kalorama Information
... examines and estimates the market for vaccines that have yet to be launched.    What diseases may see a prophylactics vaccine option in the coming years? Which vaccines will have the most successful business model? Who are ...  |  read more...
USD 3,995
Insecticides in the Philippines
7/28/2011 | published by: Euromonitor International
... its occurrence through educational campaigns, free regular fumigation and the elimination of possible mosquito breeding sites. Euromonitor International's Insecticides in Philippines market report offers a comprehensive guide to the size and shape of the market ...  |  read more...
USD 900
Dengue - Pipeline Review, Q1 2011
3/29/2011 | published by: Global Markets Direct
... with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dengue. 'Dengue - Pipeline Review, Q1 2011' is built using data and information ...  |  read more...
USD 500
MarketVIEW: Dengue vaccines
7/1/2012 | published by: VacZine Analytics
... death as observed in dengue haemorrhagicfever (DHF) and dengue shock syndrome (DSS). Importantly, of the 22,000 estimated deaths per year, the large majority are inchildren ( Although the search for a dengue vaccine has been ...  |  read more...
USD 10,995
Competitor Analysis: Dengue Virus Vaccines and Therapeutics
7/1/2012 | published by: La Merie Publishing
... of Dengue fever as of July 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the ...  |  read more...
USD 729